ADVANCED METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
Clinical trials for ADVANCED METASTATIC CASTRATION-RESISTANT PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED METASTATIC CASTRATION-RESISTANT PROSTATE CANCER trials appear
Sign up with your email to follow new studies for ADVANCED METASTATIC CASTRATION-RESISTANT PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New radiation drug targets Hard-to-Treat prostate cancer in first human trial
Disease control Recruiting nowThis study tests a new drug, 225Ac-PSMA-Trillium, in people with advanced prostate cancer that has spread and stopped responding to hormone therapy. The drug delivers radiation directly to cancer cells to damage them. The main goals are to check safety, find the best dose, and se…
Matched conditions: ADVANCED METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
Phase: PHASE1 • Sponsor: Bayer • Aim: Disease control
Last updated May 17, 2026 05:43 UTC
-
New hope for tough prostate cancer: experimental drug INV-9956 enters human trials
Disease control Recruiting nowThis study tests an experimental drug called INV-9956 in men with advanced prostate cancer that has spread and stopped responding to standard hormone therapy. The goal is to find a safe dose and see if the drug can shrink tumors or slow the cancer's growth. About 84 adult men wil…
Matched conditions: ADVANCED METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
Phase: PHASE1, PHASE2 • Sponsor: Shenzhen Ionova Life Sciences Co., Ltd. • Aim: Disease control
Last updated May 12, 2026 13:43 UTC